Portal de Periódicos da CAPES

Type 2 Diabetes: Treat to Target

2004; Lippincott Williams & Wilkins; Volume: 29; Issue: 1 Linguagem: Inglês

10.1097/00006205-200401000-00008

1538-8662

Martha M. Funnell, Davida F. Kruger,

Diabetes and associated disorders

Traditionally, practitioners have reserved insulin therapy for patients with type 2 diabetes until diet, exercise, and treatment with oral agents have failed to maintain glycemic control. Increasing evidence, however, supports advancing insulin therapy earlier in treating diabetes, not only to normalize glycemic control and emulate normal physiologic insulin secretion, but also to delay or prevent disease-associated comorbidity.